Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Colleen Marie Feltmate, M.D.

Concepts (279)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms17202413862.580 Why?
Hysterectomy1120248661.820 Why?
Cystadenocarcinoma, Serous520224801.250 Why?
Vulvar Neoplasms420182661.220 Why?
Ovarian Neoplasms23202249191.200 Why?
Hydatidiform Mole1020082550.770 Why?
Chorionic Gonadotropin1020074580.760 Why?
Leukocytosis220132510.740 Why?
Placenta Accreta120232420.660 Why?
Carcinoma4202223400.610 Why?
Paget Disease, Extramammary12018510.580 Why?
Gynecology120235340.560 Why?
Sentinel Lymph Node Biopsy320207370.560 Why?
Genital Neoplasms, Female320235380.550 Why?
Uterine Cervical Neoplasms6202220440.550 Why?
Obstetrics120236820.520 Why?
Uterine Neoplasms9201014240.500 Why?
Neoplasm Recurrence, Local13202094420.490 Why?
Carcinosarcoma120151080.460 Why?
Obesity, Morbid1202413000.440 Why?
Adenocarcinoma, Clear Cell120152180.440 Why?
Laparoscopy6202220550.430 Why?
MutS Homolog 2 Protein120122000.400 Why?
Papillomaviridae1201811400.390 Why?
Trophoblastic Tumor, Placental Site22002210.390 Why?
Fallopian Tube Neoplasms520183290.380 Why?
Papillomavirus Infections3202116400.380 Why?
Carcinoma in Situ320187880.380 Why?
Genes, BRCA2220135930.370 Why?
Adenocarcinoma5201764010.360 Why?
Genes, BRCA1220137560.350 Why?
Cell Transformation, Neoplastic2201828480.320 Why?
Carcinoma, Endometrioid320202770.310 Why?
Neoplasms, Multiple Primary120125920.310 Why?
Neoplasm Staging162022112620.300 Why?
Endometriosis220148740.300 Why?
Carcinoma, Squamous Cell3201840640.290 Why?
Patient Discharge2202434910.290 Why?
Neoplasms, Cystic, Mucinous, and Serous220201960.280 Why?
Loss of Heterozygosity220056630.260 Why?
Adenocarcinoma, Mucinous320145260.260 Why?
Ovariectomy420136130.250 Why?
Female7120243975150.250 Why?
Germ-Line Mutation1201318870.240 Why?
Microdissection120051500.230 Why?
Retrospective Studies252024819030.230 Why?
Endometrial Hyperplasia120241020.220 Why?
Heterozygote2201227980.220 Why?
Appendiceal Neoplasms120051550.220 Why?
Lymphatic Metastasis4202029160.210 Why?
Internship and Residency1202359560.210 Why?
BRCA2 Protein220238030.200 Why?
Chemotherapy, Adjuvant6202135540.200 Why?
Robotics320158260.200 Why?
Immunohistochemistry52020111160.200 Why?
Brachytherapy3202012240.200 Why?
Aged3020241717860.190 Why?
Middle Aged3520242237370.190 Why?
BRCA1 Protein2202311560.180 Why?
Lasers120059520.180 Why?
Gynecologic Surgical Procedures320232890.170 Why?
Preoperative Period220135650.170 Why?
Humans7220247689700.170 Why?
Treatment Refusal120034330.170 Why?
Adult3420242238510.160 Why?
Pregnancy182023302650.160 Why?
Lymph Node Excision3202012730.160 Why?
Uterus120226630.160 Why?
Prognosis102020300460.150 Why?
Neoplasms, Glandular and Epithelial220134890.150 Why?
Alphapapillomavirus120212190.150 Why?
Aged, 80 and over152021597390.150 Why?
Education, Medical, Continuing120238290.150 Why?
Fallopian Tubes120181790.150 Why?
Cyclin-Dependent Kinase Inhibitor p16120217100.140 Why?
Genome1200517540.140 Why?
Cervix Uteri120215770.140 Why?
Alleles2200569010.140 Why?
Cohort Studies92024418080.140 Why?
Postoperative Complications52024158890.130 Why?
Neoplasm Invasiveness4202036290.130 Why?
Antimetabolites, Antineoplastic220106470.130 Why?
Ovarian Cysts120161080.120 Why?
Genome, Human2200544560.120 Why?
Early Detection of Cancer2202132380.120 Why?
Neoplastic Syndromes, Hereditary120172490.120 Why?
Placenta1202317250.110 Why?
Radiotherapy, Adjuvant2202017930.110 Why?
Neoadjuvant Therapy5202129090.110 Why?
Ovarian Diseases120141370.110 Why?
Antineoplastic Combined Chemotherapy Protocols42018118860.110 Why?
Precancerous Conditions220189850.110 Why?
Disease-Free Survival6202268560.110 Why?
CA-125 Antigen220132810.100 Why?
Methotrexate2201017230.100 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis120173880.100 Why?
Risk Factors112023749760.100 Why?
Organoids120187450.100 Why?
New England2200610580.100 Why?
Perioperative Care2202010450.090 Why?
Ovary120169650.090 Why?
Cadherins120169060.090 Why?
Genotype12005130480.090 Why?
High-Throughput Nucleotide Sequencing2202036710.090 Why?
Cell Lineage1201825760.080 Why?
DNA Repair1201820540.080 Why?
Clinical Protocols1201514450.080 Why?
Gene Expression Regulation, Neoplastic2202086640.080 Why?
Granulosa Cell Tumor12009760.080 Why?
Peritoneal Neoplasms220137140.080 Why?
Cell Proliferation32020104860.080 Why?
Death120136830.080 Why?
Venous Thromboembolism1202118810.070 Why?
Human papillomavirus 16120102680.070 Why?
Pregnancy Complications, Neoplastic120102600.070 Why?
Survival Rate32020128730.070 Why?
Surgery, Computer-Assisted1201510060.070 Why?
Gravidity12006500.070 Why?
Insurance Coverage1201819460.070 Why?
Epithelial Cells1201837020.070 Why?
Incidence42021215470.060 Why?
Insurance, Health1201825180.060 Why?
Lymph Nodes1201734730.060 Why?
Dilatation and Curettage12004530.060 Why?
Pelvic Neoplasms120072500.060 Why?
Remission Induction2201024080.060 Why?
Blood Vessels1201011100.060 Why?
Exercise1202159540.060 Why?
Cell Movement1201652160.060 Why?
Tumor Suppressor Protein p534202029600.060 Why?
Anesthesia1201515960.060 Why?
Ki-67 Antigen120066280.050 Why?
Maternal Age120068050.050 Why?
Angiogenesis Inhibitors1201320590.050 Why?
Feasibility Studies3202153230.050 Why?
Prospective Studies62021549620.050 Why?
Telemedicine1202131100.050 Why?
Radiotherapy Dosage3201529210.050 Why?
Tumor Cells, Cultured3202061310.050 Why?
Evidence-Based Medicine1201537090.050 Why?
Genetic Techniques120054280.050 Why?
Kaplan-Meier Estimate3201965470.050 Why?
Registries5201883840.050 Why?
Medical Records2200614110.050 Why?
Genetic Predisposition to Disease32018180680.050 Why?
Artifacts1201019420.050 Why?
Ultrasonography1201460020.050 Why?
Sialoglycoproteins120023200.050 Why?
Pregnancy Complications1201429740.040 Why?
Intraoperative Complications1200711760.040 Why?
Recurrence1201385130.040 Why?
Predictive Value of Tests52020154710.040 Why?
Colposcopy120211510.040 Why?
Follow-Up Studies42018393940.040 Why?
Chorionic Gonadotropin, beta Subunit, Human22010830.040 Why?
Adnexa Uteri12019400.040 Why?
Germ Cells120236440.040 Why?
Neoplasms, Second Primary1200710600.040 Why?
Patient Readmission1201333130.040 Why?
Omentum120191680.040 Why?
Online Systems120191820.040 Why?
Estrogen Replacement Therapy2199512090.040 Why?
Diagnosis, Differential52018130210.040 Why?
Endometrium120204060.040 Why?
Genital Diseases, Female119991920.040 Why?
Estradiol2199519520.040 Why?
Treatment Outcome42019654800.040 Why?
Pregnancy Outcome1200829740.040 Why?
Diagnostic Tests, Routine120037900.040 Why?
Enzyme-Linked Immunosorbent Assay2202138130.030 Why?
Blood Loss, Surgical120216430.030 Why?
Colorectal Neoplasms1201769820.030 Why?
Sensitivity and Specificity42021147520.030 Why?
Organ Culture Techniques120187960.030 Why?
Mutation42018302660.030 Why?
Gene Expression Profiling2201695490.030 Why?
Brain Neoplasms1201792130.030 Why?
Carboplatin120187990.030 Why?
Microtubule-Associated Proteins1202010740.030 Why?
Referral and Consultation2202136280.030 Why?
Drug Resistance, Neoplasm1201053420.030 Why?
Length of Stay2202365260.030 Why?
HeLa Cells1202130760.030 Why?
Massachusetts3201888940.030 Why?
Lymphocytes, Tumor-Infiltrating1202011050.030 Why?
Estrone119952340.030 Why?
Triage120219970.030 Why?
Deoxycytidine120188880.030 Why?
Reverse Transcriptase Polymerase Chain Reaction2201645920.030 Why?
Polysaccharides1202010240.030 Why?
Organs at Risk120153680.030 Why?
Observer Variation1201926230.030 Why?
Prolactin119956270.030 Why?
Pyrazines1201812060.030 Why?
Apoptosis2202095270.030 Why?
Patient Positioning120153320.020 Why?
Xenograft Model Antitumor Assays1202036210.020 Why?
Appendicitis119996890.020 Why?
Fluorodeoxyglucose F181202020560.020 Why?
Obesity12014130910.020 Why?
Adolescent52020892440.020 Why?
Fluorescent Antibody Technique1201624740.020 Why?
Killer Cells, Natural1202022110.020 Why?
DNA Replication1201814280.020 Why?
Hyperglycemia1202013890.020 Why?
Motivation1202120250.020 Why?
Radiopharmaceuticals1202027340.020 Why?
Cancer Care Facilities120134280.020 Why?
Organoplatinum Compounds120124080.020 Why?
Dactinomycin120103050.020 Why?
Gravitation12009820.020 Why?
Risk2201496210.020 Why?
Etoposide120106390.020 Why?
Microscopy, Fluorescence1201626350.020 Why?
Taxoids120126680.020 Why?
Ethanol1199513310.020 Why?
Biopsy1202068050.020 Why?
Combined Modality Therapy2201485590.020 Why?
Cell Culture Techniques1201616670.020 Why?
Pyrazoles1201820290.020 Why?
Magnetic Resonance Imaging12015368540.020 Why?
Pilot Projects1202187480.020 Why?
Gene Regulatory Networks1201617520.020 Why?
Radiotherapy, Intensity-Modulated120138120.020 Why?
Contraceptives, Oral120095610.020 Why?
CD8-Positive T-Lymphocytes1202046510.020 Why?
Neoplasm, Residual1201210190.020 Why?
Risk Assessment32020243330.020 Why?
Menopause1199516560.020 Why?
Radiotherapy Planning, Computer-Assisted1201516790.020 Why?
Tomography, X-Ray Computed22020207760.020 Why?
Parity120099310.020 Why?
Curettage12005740.020 Why?
Postmenopause1199525190.020 Why?
RNA, Messenger22016128060.020 Why?
Consensus1201532140.020 Why?
Insulin1202066100.020 Why?
Blood Glucose1202064350.020 Why?
Alcohol Drinking2199540450.020 Why?
Organ Size1201022680.020 Why?
Family Health1200912550.010 Why?
Genes, p53120077160.010 Why?
Cyclophosphamide1201022270.010 Why?
Radiography1201569910.010 Why?
Body Mass Index22014130550.010 Why?
Decision Trees120065090.010 Why?
Randomized Controlled Trials as Topic12021104000.010 Why?
Neoplasm Metastasis1201349260.010 Why?
DNA Methylation1201744320.010 Why?
Administration, Cutaneous219957160.010 Why?
Apoptosis Regulatory Proteins1200711510.010 Why?
Survival Analysis12014101150.010 Why?
Age Distribution1200728750.010 Why?
Risk Reduction Behavior1200711190.010 Why?
Reproducibility of Results22014202450.010 Why?
Phenotype12018167310.010 Why?
Practice Guidelines as Topic1201874600.010 Why?
Osteopontin120023110.010 Why?
Cluster Analysis1200627320.010 Why?
Ultrasonography, Prenatal1200717710.010 Why?
Cross-Over Studies2199521080.010 Why?
Oligonucleotide Array Sequence Analysis1200638100.010 Why?
Clinical Trials as Topic1201380550.010 Why?
Positron-Emission Tomography1201366730.010 Why?
Cell Differentiation12014116840.010 Why?
Patient Compliance1200427010.010 Why?
Mice12020820720.010 Why?
Young Adult12020601310.010 Why?
Age Factors12009184350.010 Why?
Case-Control Studies12009222960.010 Why?
Random Allocation1199523940.010 Why?
Gene Expression1200276030.010 Why?
Animals120201693350.000 Why?
Acute Disease1199972450.000 Why?
Male120053652030.000 Why?
Analysis of Variance1199562360.000 Why?
Double-Blind Method11995124670.000 Why?
United States12004731860.000 Why?
Child11999809600.000 Why?
Feltmate's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (279)
Explore
_
Co-Authors (78)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.